Optimum control of insulin resistance and lipid profile in post-menopausal women Nutritional, Metabolic, Endocrine
Conditions
Interventions
The study has involved 155 postmenopausal women with metabolic syndrome recruited at visit for clinical-instrumental surveillance program for breast cancer prevention within National Cancer Institute
Sponsors
Pharma Dancan s.r.l. (Italy)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Post-menopausal women affected by metabolic syndrome at any age participating to our clinical-instrumental program of surveillance for breast cancer prevention 2. Willing to be assigned to any of the study intervention groups
Exclusion criteria
Exclusion criteria: 1. Women taking oral hypoglycemic drugs or insulin 2. Women taking statins
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Reduction of more than 20% of HOMA-IR index and of triglycerides 2. Improvement of high density lipoprotein cholesterol 3. Reduction of anthropometric features such as body mass index, waist and hip ratio Measured at at baseline and at six months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Good control of metabolic syndrome helping diet results with insulin sensitizing supplements | — |
Countries
Italy
Outcome results
None listed